Literature DB >> 4459738

Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies.

G J Hum, D L Bogdon, J R Bateman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4459738     DOI： 10.1159/000224961

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  1 in total

1.  Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA).

Authors:  S K Shipp; H B Muss; M A Westrick; M R Cooper; D V Jackson; F C Richards; D R White; J J Stuart; R M Christian; W Ramseur
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.